Schedule 13G filing

PRICE T ROWE ASSOCIATES INC /MD/ disclosed a 16.6% stake in Beta Bionics, Inc. (BBNX)

Schedule 13G · Filed Oct 7, 2026

PRICE T ROWE ASSOCIATES INC /MD/ reported owning 16.6% of Beta Bionics, Inc. (BBNX) (8,943,061 shares) in a Schedule 13G filed Oct 7, 2026.

A 13G is a passive stake: the holder does not plan to push for changes.

Stake

Beta Bionics, Inc.

Stake

16.6% stake

More BBNX insider and Congress trades

Share this trade

From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.